Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr;10(1):45-50.
doi: 10.15420/aer.2020.46.

Leadless Left Ventricular Endocardial Pacing and Left Bundle Branch Area Pacing for Cardiac Resynchronisation Therapy

Affiliations
Review

Leadless Left Ventricular Endocardial Pacing and Left Bundle Branch Area Pacing for Cardiac Resynchronisation Therapy

Baldeep S Sidhu et al. Arrhythm Electrophysiol Rev. 2021 Apr.

Abstract

Cardiac resynchronisation therapy is an important intervention to reduce mortality and morbidity, but even in carefully selected patients approximately 30% fail to improve. This has led to alternative pacing approaches to improve patient outcomes. Left ventricular (LV) endocardial pacing allows pacing at site-specific locations that enable the operator to avoid myocardial scar and target areas of latest activation. Left bundle branch area pacing (LBBAP) provides a more physiological activation pattern and may allow effective cardiac resynchronisation. This article discusses LV endocardial pacing in detail, including the indications, techniques and outcomes. It discusses LBBAP, its potential benefits over His bundle pacing and procedural outcomes. Finally, it concludes with the future role of endocardial pacing and LBBAP in heart failure patients.

Keywords: Cardiac resynchronisation therapy; WiSE-CRT; endocardial pacing; left bundle branch area pacing.

PubMed Disclaimer

Conflict of interest statement

Disclosure: BSS is funded by NIHR and received speaker fees from EBR Systems outside of the submitted work. JG has received project funding from Rosetrees Trust outside of the submitted work. JG, MKE and VM have received fellowship funding from Abbott outside of the submitted work. CAR receives research funding and/or consultation fees from Abbott, Medtronic, Boston Scientific and MicroPort outside of the submitted work. SN has no conflicts of interest to declare. The study was supported by the Wellcome/EPSRC Centre for Medical Engineering (WT203148/Z/16/Z).

Figures

Figure 1:
Figure 1:. Components of the WiSE-CRT System
Figure 2:
Figure 2:. Acoustic Window Screening and WiSE-CRT Implantation
Figure 3:
Figure 3:. Anchoring of the Endocardial Electrode

Similar articles

Cited by

References

    1. Cleland JG,, Daubert JC,, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539–49. doi: 10.1056/NEJMoa050496. - DOI - PubMed
    1. Bristow MR,, Saxon LA,, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350:2140–50. doi: 10.1056/NEJMoa032423. - DOI - PubMed
    1. European Heart Rhythm Association, European Society of Cardiology, Heart Rhythm Society, et al. 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Europace. 2012;14:1236–86. doi: 10.1093/europace/eus222. - DOI - PubMed
    1. Sidhu BS,, Gould J,, Sieniewicz BJ, et al. Complications associated with cardiac resynchronization therapy upgrades versus de novo implantations. Expert Rev Cardiovasc Ther. 2018;16:607–15. doi: 10.1080/14779072.2018.1498783. - DOI - PubMed
    1. Arnold AD,, Whinnett ZI,, Vijayaraman P. His-Purkinje conduction system pacing: state of the art in 2020. Arrhythm Electrophysiol Rev. 2020;9:136–45. doi: 10.15420/aer.2020.14. - DOI - PMC - PubMed